6533b857fe1ef96bd12b42f1

RESEARCH PRODUCT

P0792 : Baseline factors associated with increased SVR rates in 123 treatment-naïve chronic HCV genotype 1 patients treated with a shortened 12-week simeprevir plus pegylated interferon and ribavirin regimen: a multivariate analysis

Christoph SarrazinOliver LenzChristophe MorenoG. Van DoorenAntonio CraxìMaria ButiI. Lonjon-domanecGraham R. FosterTarik AsselahPeter BuggischMichael GschwantlerR RyanM. Schlag

subject

Simeprevirmedicine.medical_specialtyMultivariate analysisHepatologybusiness.industryRibavirinVirologyGastroenterologyTherapy naiveRegimenchemistry.chemical_compoundHcv genotype 1chemistryPegylated interferonInternal medicinemedicinebusinessmedicine.drughttps://doi.org/10.1016/s0168-8278(15)30995-8